An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer. (Record no. 26272195)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02344 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517110132.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201711s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1556-1380 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.jtho.2016.07.013 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Novello, Silvia |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20171121 |
245 00 - TITLE STATEMENT | |
Title | An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
Date of publication, distribution, etc. | 02 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 383-389 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adenocarcinoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Large Cell |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cisplatin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pemetrexed |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Scagliotti, Giorgio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Castro, Gilberto |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kiyik, Murat |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kowalyszyn, Rubén |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deppermann, Karl-Matthias |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arriola, Edurne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bosquee, Lionel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Novosiadly, Ruslan D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nguyen, Tuan S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Forest, Amelie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tang, Shande |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kambhampati, Siva Rama Prasad |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cosaert, Jan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Reck, Martin |
773 0# - HOST ITEM ENTRY | |
Title | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
Related parts | vol. 12 |
-- | no. 2 |
-- | p. 383-389 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jtho.2016.07.013">https://doi.org/10.1016/j.jtho.2016.07.013</a> |
Public note | Available from publisher's website |
No items available.